ARCHIVES

NCI To Recompete Drug Discovery Groups In 2003 As Program Nears Its 20th Year

This article is from The Cancer Letter archive.

Vol. 28 No. 44 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

June 28, 2013

NIH Not Proactive, Healy Tells NCAB ‘Beset’ By Issues

February 12, 1993

Senate Subcommittee Okays $1 billion For NCI In FY 1980, Agrees To Block Obey Reprogramming

June 15, 1979

Study: Keytruda Improves PFS In Ipilimumab-Refactory Disease

November 28, 2014

US Could Lose Leadership In Research If NIH Budget Is Cut, ASCO President Says

June 2, 1995

NCI Backed Studies Indicate Overweight Not Much Of a Cancer Risk Factor

June 19, 1987